Sfoglia per AUTORE
KEARY IP
Collezione ASL Biella

  

Items : 1

A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age. in PloS one / PLoS One. 2023 Aug 10;18(8):e0289828. doi: 10.1371/journal.pone.0289828. eCollection 2023.

2023
ASL Biella

Keary IP; Ravasio R; Fullarton JR; Manzoni P; Lanari M; Paes BA; Carbonell-Estrany X; Baraldi E; Tarride JÉ; Rodgers-Gray B;